Back to search

Article

CD5L is a Potential Hepatocellular Carcinoma Biomarker for Clinical prognostic and immunotherapy

2023-02-16

Abstract excerpt

CD5L acts as an important regulator of inflammation by suppressing the immune response and blocking the secretion of pro-inflammatory cytokines. However, systematic evaluations of CD5L-related genes in human cancers are lacking, particularly in their predictive role in hepatocellular carcinoma progression. Here, we obtained data from the Tumor Genome Atlas (TCGA), an open database website, to evaluate CD5L mRNA ex...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
45bb8103-97cd-5183-a4d6-aae63540b05d
DOI
10.21203/rs.3.rs-2586807/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CD5L is a Potential Hepatocellular Carcinoma Biomarker for Clinical prognostic and immunotherapyDOI 10.21203/rs.3.rs-2586807/v1
Select a neighboring publication to make it the new centre.